Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome*
Emir Festić(Jacksonville College), Joseph E. Levitt(Stanford University), Vikas Bansal(Mayo Clinic in Florida), Adijat T. Asuni(Stanford University), Michael A. Matthay(University of California, San Francisco), Richard Hinds(Mayo Clinic), Rodrigo Cartin‐Ceba, Ognjen Gajic(Mayo Clinic), Daniel Talmor(Harvard University), Govindarajan Rajagopalan(Mayo Clinic in Arizona), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center), Gordon Carr, Ryan D. Frank(Mayo Clinic)
Cited by 91
Related Papers
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2002|898
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis
|Nature Communications|2020|780
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*
|Critical Care Medicine|2005|729